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Impact of glycaemic control on circulating endothelial progenitor cells and arterial stiffness in 
patients with type 2 diabetes mellitus
WS Yue, KK Lau, CW Siu, M Wang, GH Yan, KH Yiu, HF Tse
Department of Medicine, Queen Mary Hospital, Hong Kong
introduction: Patients with type 2 diabetes mellitus (DM) have increased risk of endothelial dysfunction and 
arterial stiffness. Levels of circulating endothelial progenitor cells (EPCs) are also reduced in hyperglycaemic 
states. However, the relationships between glycaemic control, levels of EPCs and arterial stiffness are unknown.
Methods: We measured circulating EPCs and brachial-ankle pulse wave velocity (baPWV) in 234 patients with 
type 2 DM and compared with 121 age- and sex-matched controls. 
Results: Patients with DM had significantly lower circulating LogCD34+/KDR+ and LogCD133/KDR+ EPC counts, 
and higher LogbaPWV compared with controls (all P<0.05). Among those 120/234 (51%) of DM patients with 
satisfactory glycaemic control (defined by haemoglobin A1c, HbA1c ≤6.5%), they had significantly higher 
circulating LogCD34/KDR+ and LogCD133/KDR+ EPC counts, and lower LogbaPWV compared with patients 
with poor glycaemic control (all P<0.05). The circulating levels of Log CD34/KDR+ EPC (r= –0.46, P<0.001) and 
LogCD133/KDR+ EPC counts (r= –0.45, P<0.001) were negatively correlated with LogbaPWV. While the level of 
HbA1c positively correlated with LogbaPWV (r=0.20, P<0.05) and negatively correlated with circulating levels of 
LogCD34/KDR+ EPC (r= –0.40, P<0.001) and LogCD133/KDR+ EPC (r= –0.41, P<0.001). Multivariate analysis revealed 
that HbA1c, LogCD34/KDR+ and LogCD133/KDR+ EPC counts were independent predictors of LogbaPWV (P<0.05). 
Conclusion: In patients with type 2 DM, the level of circulating EPCs and arterial stiffness were closely related to 
their glycaemic control. DM patients with satisfactory glyacemic control had higher levels of circulating EPCs 
and were associated with lower arterial stiffness.
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BKCa and hEAG channels modulate proliferation and differentiation of human bone marrow–
derived mesenchymal stem cells
YY Zhang, HF Tse, CP Lau, GR Li
Department of Medicine, The University of Hong Kong, Hong Kong
introduction: Bone marrow–derived mesenchymal stem cells (MSCs) are a promising cell source for 
regenerative medicine. However, cellular physiology is not fully understood in human MSCs. The present study 
was to determine the potential role of the dominant functional ion channels, large-conductance Ca2+-activated 
potassium (BKCa) channel, ether-à-go-go potassium (hEAG1) channel in regulating cell functions, including 
proliferation and differentiation, in human MSCs.
Methods: Ionic currents were recorded using a whole cell patch-clamp technique. Cell proliferation assay 
was made with MTT and 3H-thymidine incorporation approaches. Cell cycle distribution was determined 
by flowcytometry. Lentivirus-based shRNA was used to knock down ion channels specifically. RT-PCR and 
Western blot analysis were applied. Adipogenic differentiation was visualised by Oil red O staining. Osteogenic 
differentiation was determined by alizarin red S staining. 
Results: We found that paxilline and astemizole respectively reduced BKCa and hEAG1 current in human MSCs. 
The cell proliferation assay with MTT and 3H-thymidine incorporation methods revealed that the inhibition of 
BKCa with paxilline and hEAG1 with astemizole decreased cell proliferation and reduced DNA synthesis rate in a 
dose-dependent manner. Flowcytometry analysis displayed that paxilline and astemizole accumulated human 
MSCs at G0/G1 phase, and decreased cell population of S phase. Moreover, lentivirus-based shRNAs targeted to 
BKCa or hEAG1 channel remarkably reduced both mRNA and protein expression of BKCa or hEAG1 channel; and 
proliferation of human MSCs was reduced by BKCa-shRNAs or hEAG1-shRNAs. We also found these effects were 
accompanied by a decreased expression of cyclin D1 and cyclin E. In addition, we found that knock-down of 
BKCa or hEAG1 channels reduced differentiation ability of hMSCs. The expression level of PPARγ or osteocalcin 
was decreased after the knock-down of KCNH1 or KCNMA1 respectively when hMSCs were induced to 
adipogenic or osteogenic differentiation.
Conclusion: Our results demonstrate that BKCa and hEAG1 channels participate in the regulation of cell 
proliferation by promoting G0/G1 cells into cell cycling progression, and are also closely involved in cell 
differentiation in human MSCs.
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